Rapid Intravenous Infusion of Velaglucerase Alfa (VPRIV) in Treatment-naive Patients With Type 1 Gaucher Disease
Clinical trial NCT03702361 · COMPLETED
Trial details
- NCT number
- NCT03702361
- Sponsor
- Shaare Zedek Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-04
- Primary completion
- 2019-09-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.